For hay fever sufferers, the arrival of spring and summer can bring more than just sunshine and warmth. It can also herald the onset of seasonal allergies and bothersome symptoms. While over-the-counter medications and nasal sprays offer relief for many, some individuals with severe symptoms turn to hay fever injections as a more potent solution. However, recent developments have sparked controversy surrounding injections, particularly the NHS decision to discontinue Kenalog injections as hay fever treatment.
Kenalog injections work by temporarily suppressing the immune system. The injection contains a steroid to reduce inflammation and alleviate symptoms. This treatment is not suitable for individuals with mild hay fever symptoms, as it may weaken the immune system, making patients more vulnerable to other infections, such as flu, chickenpox, and shingles. Additionally, these injections may result in potential side effects.
Here we'll delve into the controversy surrounding hay fever injections. We will explore why the NHS stopped offering Kenalog injections, discuss the effectiveness of this treatment, and address whether individuals can still obtain them from their GP.
While some individuals report significant symptom relief with the injection, particularly in cases of severe hay fever, the effectiveness of this treatment remains a subject of debate. Some studies suggest that corticosteroid injections can provide rapid and substantial relief from hay fever symptoms, including sneezing, itching, and nasal congestion. However, other research indicates that the benefits of the injection may be short-lived and that long-term use could potentially lead to adverse effects such as nasal mucosal atrophy, septal perforation, and systemic side effects.
Kenalog hay fever injections, also known as corticosteroid injections, were previously offered by the NHS as a treatment option for severe hay fever symptoms. However, in recent years, concerns have emerged regarding potential side effects and long-term risks associated with corticosteroid injections. These concerns prompted the NHS to reassess the safety and effectiveness of Kenalog injections for hay fever treatment. In 2018, the NHS made the decision to discontinue Kenalog injections due to safety concerns and a lack of robust evidence supporting their long-term effectiveness. Some of these side effects include redness or pain at the injection site, stomach pain, headache, dizziness, trouble sleeping or weight gain.
Following the NHS decision to discontinue these injections, individuals may no longer be able to obtain them from their GP as a routine treatment for hay fever. However, in certain cases where symptoms are severe and unresponsive to other treatments, GPs may consider prescribing corticosteroid injections on a case-by-case basis, taking into account the individual's medical history, symptoms, and treatment preferences. It's essential to discuss treatment options with your GP and weigh the potential risks and benefits before considering this as a treatment option.
At Private Medical Clinic, we offer in-depth consultations surrounding all hay fever treatments, and the injection is considered as a last option for patients with severe symptoms. Our doctors will thoroughly assess your medical history and current health status before recommending this treatment.
Hay fever is a manageable allergy, and there are many treatment options available. Do not suffer in silence. Click here to book your consultation with one of our doctors.
If you're considering treatment, you can visit one of our clinics across the UK. Explore the locations below to find your nearest option.
Dr. Ibrahim Mutlib (BMBS, BMedSci) is an experienced GP with specialist interests in mental health, gastrointestinal health, and respiratory medicine. A clinical leader and published author, he is passionate about innovative, patient-centred care that supports both physical and emotional wellbeing.
.avif)
